Physician profile
Deana Morrison
NPI 1487244018
$1,288.86
in general payments reported to CMS, 2019-2025
16 companies · $536 in 2025
The $536 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.82 · 2023: $251 · 2024: $465 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,252.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $389.67 | 2023-2025 | Stelara, Tremfya, Simponi Aria |
| Genzyme Corporation | $167.19 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $142.72 | 2023-2025 | Entyvio |
| Ardelyx, INC. | $116.20 | 2024-2025 | Ibsrela |
| Madrigal Pharmaceuticals | $87.20 | 2024-2025 | Rezdiffra, Resmetirom |
| Celgene Corporation | $85.21 | 2023-2024 | Zeposia |
| Fresenius Kabi USA, LLC | $54.33 | 2024 | Idacio |
| Mallinckrodt Hospital Products INC. | $40.58 | 2024 | Terlivaz |
| Amgen INC. | $37.83 | 2025 | Uplizna |
| Exact Sciences Corporation | $34.70 | 2023-2024 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $29.76 | 2024-2025 | Voquezna |
| Braintree Laboratories, INC. | $23.21 | 2024 | Suflave, Sutab |
| Evoke Pharma, INC. | $22.98 | 2024 | |
| Abbvie INC. | $20.46 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $19.90 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $16.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deana Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.